302 related articles for article (PubMed ID: 7724182)
21. Diabetes Control and Complications Trial (DCCT): results of feasibility study. The DCCT Research Group.
Diabetes Care; 1987; 10(1):1-19. PubMed ID: 2882967
[TBL] [Abstract][Full Text] [Related]
22. [Prevalence of chronic diabetes complications depending on the method of insulin therapy in children and adolescents with type 1 diabetes].
Florys B; Ołdytowska A; Głowińska B; Peczyńska J; Urban M
Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2004; 10(1):31-9. PubMed ID: 15355737
[TBL] [Abstract][Full Text] [Related]
23. Effect of pregnancy on microvascular complications in the diabetes control and complications trial. The Diabetes Control and Complications Trial Research Group.
Diabetes Control and Complications Trial Research Group
Diabetes Care; 2000 Aug; 23(8):1084-91. PubMed ID: 10937502
[TBL] [Abstract][Full Text] [Related]
24. Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy.
; Lachin JM; Genuth S; Cleary P; Davis MD; Nathan DM
N Engl J Med; 2000 Feb; 342(6):381-9. PubMed ID: 10666428
[TBL] [Abstract][Full Text] [Related]
25. Exogenous insulin administration and cardiovascular risk in non-insulin-dependent and insulin-dependent diabetes mellitus.
Genuth S
Ann Intern Med; 1996 Jan; 124(1 Pt 2):104-9. PubMed ID: 8554200
[TBL] [Abstract][Full Text] [Related]
26. Effects of intensive diabetes therapy on neuropsychological function in adults in the Diabetes Control and Complications Trial.
Ann Intern Med; 1996 Feb; 124(4):379-88. PubMed ID: 8554246
[TBL] [Abstract][Full Text] [Related]
27. Epidemiology of Diabetes Interventions and Complications (EDIC). Design, implementation, and preliminary results of a long-term follow-up of the Diabetes Control and Complications Trial cohort.
Epidemiology of Diabetes Interventions and Complications (EDIC) Research Group
Diabetes Care; 1999 Jan; 22(1):99-111. PubMed ID: 10333910
[TBL] [Abstract][Full Text] [Related]
28. Evaluations of retinopathy in the VA Cooperative Study on Glycemic Control and Complications in Type II Diabetes (VA CSDM). A feasibility study.
Emanuele N; Klein R; Abraira C; Colwell J; Comstock J; Henderson WG; Levin S; Nuttall F; Sawin C; Silbert C; Lee HS; Johnson-Nagel N
Diabetes Care; 1996 Dec; 19(12):1375-81. PubMed ID: 8941467
[TBL] [Abstract][Full Text] [Related]
29. Effect of intensive diabetes therapy on the progression of diabetic retinopathy in patients with type 1 diabetes: 18 years of follow-up in the DCCT/EDIC.
; Lachin JM; White NH; Hainsworth DP; Sun W; Cleary PA; Nathan DM
Diabetes; 2015 Feb; 64(2):631-42. PubMed ID: 25204977
[TBL] [Abstract][Full Text] [Related]
30. Metaanalysis of the effects of intensive glycemic control on late complications of type I diabetes mellitus.
Wang PH; Lau J; Chalmers TC
Online J Curr Clin Trials; 1993 May; Doc No 60():[5023 words; 37 paragraphs]. PubMed ID: 8306007
[TBL] [Abstract][Full Text] [Related]
31. Rapid tightening of blood glucose control leads to transient deterioration of retinopathy in insulin dependent diabetes mellitus: the Oslo study.
Dahl-Jørgensen K; Brinchmann-Hansen O; Hanssen KF; Sandvik L; Aagenaes O
Br Med J (Clin Res Ed); 1985 Mar; 290(6471):811-5. PubMed ID: 3919804
[TBL] [Abstract][Full Text] [Related]
32. Effects of prior intensive insulin therapy on cardiac autonomic nervous system function in type 1 diabetes mellitus: the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications study (DCCT/EDIC).
Pop-Busui R; Low PA; Waberski BH; Martin CL; Albers JW; Feldman EL; Sommer C; Cleary PA; Lachin JM; Herman WH;
Circulation; 2009 Jun; 119(22):2886-93. PubMed ID: 19470886
[TBL] [Abstract][Full Text] [Related]
33. Cost-effectiveness of intensive insulin therapy for type 2 diabetes: a 10-year follow-up of the Kumamoto study.
Wake N; Hisashige A; Katayama T; Kishikawa H; Ohkubo Y; Sakai M; Araki E; Shichiri M
Diabetes Res Clin Pract; 2000 Jun; 48(3):201-10. PubMed ID: 10802159
[TBL] [Abstract][Full Text] [Related]
34. Insights from the diabetes control and complications trial/epidemiology of diabetes interventions and complications study on the use of intensive glycemic treatment to reduce the risk of complications of type 1 diabetes.
Genuth S
Endocr Pract; 2006; 12 Suppl 1():34-41. PubMed ID: 16627378
[TBL] [Abstract][Full Text] [Related]
35. Epidemiology of severe hypoglycemia in the diabetes control and complications trial. The DCCT Research Group.
Am J Med; 1991 Apr; 90(4):450-9. PubMed ID: 2012085
[TBL] [Abstract][Full Text] [Related]
36. Effect of glycemic control on microvascular complications in patients with type I diabetes mellitus.
Rosenstock J; Friberg T; Raskin P
Am J Med; 1986 Dec; 81(6):1012-8. PubMed ID: 3541587
[TBL] [Abstract][Full Text] [Related]
37. A comparison of the study populations in the Diabetes Control and Complications Trial and the Wisconsin Epidemiologic Study of Diabetic Retinopathy.
Klein R; Moss S
Arch Intern Med; 1995 Apr; 155(7):745-54. PubMed ID: 7695463
[TBL] [Abstract][Full Text] [Related]
38. The Diabetes Control and Complications Trial (DCCT). Design and methodologic considerations for the feasibility phase. The DCCT Research Group.
Diabetes; 1986 May; 35(5):530-45. PubMed ID: 2869996
[TBL] [Abstract][Full Text] [Related]
39. Effect of intensive therapy on the development and progression of diabetic nephropathy in the Diabetes Control and Complications Trial. The Diabetes Control and Complications (DCCT) Research Group.
Kidney Int; 1995 Jun; 47(6):1703-20. PubMed ID: 7643540
[TBL] [Abstract][Full Text] [Related]
40. Progression of retinopathy during pregnancy in type 1 diabetic women treated with insulin lispro.
Loukovaara S; Immonen I; Teramo KA; Kaaja R
Diabetes Care; 2003 Apr; 26(4):1193-8. PubMed ID: 12663596
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
